Arazy Group Consultants Inc. reported that Saudi Arabia's SFDA has established new lifecycle risk communication requirements under guidance MDS-G-029, requiring manufacturers to integrate safety communication into post-market surveillance systems and submit dual-language safety updates through the GHAD platform.

Arazy Group Consultants Inc. is the inventor of global medtech registration technology providing services and products designed to streamline, simplify, and expedite international market access affairs for all types of medical and IVD devices. With the launch of LICENSALE® - Global Medtech Registration System in 2013, Arazy Group took the lead on the provision of advanced registration and license management technology solutions, designed specifically for the medical and IVD device industry. Staying true to its company mission to make the best medical devices and medical practice available to patient and physicians around the world, LICENSALE® delivered thousands of new products registrations, amendments, renewals, and transfers of licenses over the past seven years. Leveraging on their experience and the latest advancement in software, database management, machine learning and A.I., Arazy Group developed the next generation in MedTech registration and license management software- LICENSALE® 2.0, REGISLATE® and the EUDAMEDtech© system Advanced solutions rapidly adopted by the global medtech industry and becoming the gold standard of market access license management. Arazy Group is based in Vancouver, British Columbia, Canada. Arazy Group has additional offices in the US, Argentina, Israel, Turkey, Korea and throughout Europe and is operating globally in 140 countries. Please contact us for more information or visit our website: http://arazygroup.com.